Viewpoint
Eosinophil lysis and free granules: an in vivo paradigm for cell activation and drug development

https://doi.org/10.1016/S0165-6147(97)01042-0Get rights and content

Abstract

Release of cytotoxic granule proteins from activated eosinophil granules is considered to be a key pathogenic mechanism in eosinophilic diseases. Degenerated eosinophils and extracellular eosinophil granules have been repeatedly depicted. The present overview describes evidence that eosinophil lysis and distribution of free osinophil granules (as opposed to ‘classical degranulation’) is an important mechanism by which eosinophils affect their surroundings. Here, Carl Persson and Jonas Erjefält summarize how recent reports on the induction of eosinophil lysis in vivo provide a new paradigm for eosinophil activation and thus constitute a novel basis for pharmacological manipulations in eosinophilic diseases.

References (70)

  • Korsgren, M., Erjefält, J. S., Erjefält, I., Sundler, F. and Persson, C. G. A. Am. J. Respir. Crit. Care Med. Abstr....
  • J.S. Erjefält et al.

    Am. J. Respir. Crit. Care Med.

    (1996)
  • C.G.A. Persson

    J. Clin. Exp. Allergy

    (1996)
  • H-U. Simon et al.

    Immunol. Today

    (1995)
  • G. Majno et al.

    Am. J. Pathol.

    (1995)
  • Y. Ohashi et al.

    Am. Rev. Respir. Dis.

    (1992)
  • A. Janin

    Thorax

    (1993)
  • A.M. Dvorak et al.

    Lab. Invest.

    (1990)
  • L.B. Martin et al.

    Int. Arch. Allergy Immunol.

    (1996)
  • C.G.A. Persson

    Eur. Respir. Rev.

    (1994)
  • S.J. Meltzer

    J. Am. Med. Assoc.

    (1910)
  • H. Schlecht et al.

    Dtsch. Arch. Klin. Med.

    (1912)
  • P. Kallós et al.

    Acta Med. Scand.

    (1937)
  • G.J. Gleich et al.

    J. Exp. Med.

    (1973)
  • D.A. Griffiths-Johnson et al.

    Biochem. Biophys. Res. Commun.

    (1993)
  • J.S. Erjefält et al.

    Cell Tissue Res.

    (1995)
  • J.S. Erjefält et al.

    Microvasc. Res.

    (1994)
  • Erjefält, J. S., Korsgren, M., Nilsson, M., Sundler, F. and Persson, C. G. A. Clin. Exp. Allergy (in...
  • R.H. Gundel et al.

    J. Appl. Physiol.

    (1990)
  • S-Y. Eum et al.
  • Erjefält, J.S. et al. Am. J. Respit. Crit. Med. Abstr. (in...
  • M. Korsgren et al.

    J. Exp. Med.

    (1997)
  • S.J.D. Bell et al.

    Cell. Immunol.

    (1996)
  • E. Duvall et al.

    Immunol. Today

    (1986)
  • P.K. Jeffrey

    Am. Rev. Respir. Dis.

    (1992)
  • W.V. Filley et al.

    Lancet

    (1982)
  • R. Beasley et al.

    Am. Rev. Respir. Dis.

    (1989)
  • A.A. Liebow et al.

    Medicine

    (1969)
  • A.M. Dvorak
  • K.M. Leiferman
  • R.I. Abu-Ghazaleh et al.

    J. Immunol.

    (1989)
  • T. Fujisawa et al.

    J. Immunol.

    (1990)
  • A.M. Dvorak et al.

    Am. J. Pathol.

    (1991)
  • Cited by (77)

    • Eosinophils: Focus on DNA extracellular traps

      2022, Life Sciences
      Citation Excerpt :

      Human eosinophils can undergo cytolysis with intact granule release in vivo [24,25] and in vitro [25]. Over the years, the presence of membrane-bound free intact secondary granules, with their unique crystalline cores, has been documented in biopsies, tissues and secretions of different diseases, such as asthma, rhinitis, eosinophilic esophagitis and other eosinophil-associated diseases [26–30]. This curious frequent observation was, for a long time, underexplored and, for many, considered an artifact until findings in vitro challenged this point [25,31–34].

    • How to detect eosinophil ETosis (EETosis) and extracellular traps

      2021, Allergology International
      Citation Excerpt :

      Indeed, eosinopilopoietic cytokines such as GM-CSF and IL-5 markedly prolong the viability of isolated blood eosinophils in vitro. Conversely, cytolysis of eosinophils that generate extracellular free granules has been observed in inflamed tissues for more than 100 years.3 This paradoxical phenomenon of in vitro and in vivo observations can be explained by active non-apoptotic cell death.

    • Biology of Eosinophils

      2014, Middleton's Allergy: Principles and Practice: Eighth Edition
    • Eosinophil Secretory Functions

      2013, Eosinophils in Health and Disease
    • Eosinophil extracellular DNA trap cell death mediates lytic release of free secretion-competent eosinophil granules in humans

      2013, Blood
      Citation Excerpt :

      Free extracellular eosinophil granules have been documented in diverse diseases, including atopic dermatitis and nasal allergy, and they have been correlated with the severity of urticaria.4,6 Since the late 1800s, free eosinophil granules have been noted in the sputum of asthmatics, and clusters of free eosinophil granules (termed “Cfegs”) have been documented in human asthma and experimental guinea pig models of asthma.7 The release of intact, membrane-bound granules occurs via an enigmatic mode of eosinophil “degranulation” that arises from the cytolysis of eosinophils.

    • Eosinophil Secretory Functions

      2012, Eosinophils in Health and Disease
    View all citing articles on Scopus

    Scientific adviser, Preclinical R&D, Astra Draco, Lund, Sweden

    View full text